ACC Binh Duong Investment and Construction JSC (HOSE:ACC)

Aerovate Therapeutics Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Revenue	772,192	700,024	651,590	344,495	361,050	377,421
Revenue Growth (YoY)	114.29%	7.43%	89.14%	-4.58%	-4.34%	12.22%
Cost of Revenue	666,963	590,270	525,033	281,780	306,494	295,995
Gross Profit	105,229	109,754	126,558	62,716	54,556	81,427
Selling, General & Admin	15,842	19,861	30,182	26,054	19,292	19,799
Operating Expenses	15,842	19,861	30,182	26,054	19,292	19,799
Operating Income	89,388	89,893	96,376	36,662	35,264	61,627
Interest Expense	-37,513	-40,824	-44,624	-	-	-
Interest & Investment Income	9,743	14,616	17,683	6,171	2,108	3,843
Other Non Operating Income (Expenses)	409.32	339.31	3,088	967.79	11.75	155.24
EBT Excluding Unusual Items	62,027	64,024	72,523	43,801	37,384	65,626
Gain (Loss) on Sale of Assets	5.94	5.94	64.78	-	728.24	-
Other Unusual Items	3,542	3,542	14,754	-	-	-
Pretax Income	65,574	67,572	87,342	43,801	38,112	65,626
Income Tax Expense	13,275	15,061	17,187	4,517	3,836	4,223
Earnings From Continuing Operations	52,299	52,512	70,155	39,283	34,277	61,403
Minority Interest in Earnings	-622.77	-221.32	-655.23	-1,397	-	-
Net Income	51,676	52,290	69,499	37,886	34,277	61,403
Preferred Dividends & Other Adjustments	-	-	1,036	-	-	-
Net Income to Common	51,676	52,290	68,463	37,886	34,277	61,403
Net Income Growth	44.29%	-24.76%	83.45%	10.53%	-44.18%	-0.04%
Shares Outstanding (Basic)	105	105	105	10	10	10
Shares Outstanding (Diluted)	105	105	105	10	10	10
Shares Change (YoY)	988.74%	-	988.64%	-3.55%	-	-
EPS (Basic)	491.91	498.00	652.03	3928.00	3427.65	6140.26
EPS (Diluted)	491.91	498.00	652.03	3928.00	3427.65	6140.26
EPS Growth	-86.75%	-23.62%	-83.40%	14.60%	-44.18%	-0.04%
Free Cash Flow	-34,435	433,034	-379,701	-	54,445	46,882
Free Cash Flow Per Share	-327.79	4124.14	-3616.20	-	5444.47	4688.25
Dividend Per Share	-	-	-	2500.000	3000.000	4000.000
Dividend Growth	-	-	-	-16.67%	-25.00%	-
Gross Margin	13.63%	15.68%	19.42%	18.20%	15.11%	21.57%
Operating Margin	11.58%	12.84%	14.79%	10.64%	9.77%	16.33%
Profit Margin	6.69%	7.47%	10.51%	11.00%	9.49%	16.27%
Free Cash Flow Margin	-4.46%	61.86%	-58.27%	-	15.08%	12.42%
EBITDA	92,048	92,911	100,054	48,026	46,461	75,145
EBITDA Margin	11.92%	13.27%	15.35%	13.94%	12.87%	19.91%
D&A For EBITDA	2,660	3,019	3,678	11,365	11,196	13,518
EBIT	89,388	89,893	96,376	36,662	35,264	61,627
EBIT Margin	11.58%	12.84%	14.79%	10.64%	9.77%	16.33%
Effective Tax Rate	20.24%	22.29%	19.68%	10.31%	10.06%	6.44%
Revenue as Reported	772,192	700,024	651,590	344,495	361,050	377,421

Updated Aug 28, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.